Show simple item record

dc.date.accessioned2020-12-03T20:51:41Z
dc.date.available2020-12-03T20:51:41Z
dc.date.issued2020-12-03
dc.identifier.citationPan American Health Organization. Leishmaniasis: Epidemiological Report in the Americas. Number 9, December 2020. Washington, D.C.: PAHO; 2020.en_US
dc.identifier.govdocPAHO/CDE/VT/20-0041
dc.identifier.urihttps://iris.paho.org/handle/10665.2/53090
dc.description.abstractIn the Americas, leishmaniasis are a public health problem due to their magnitude and geographic distribution and because they produce clinical forms that can cause death, disability, and mutilation. In recent years, the Pan American Health Organization (PAHO)—in accordance with the mandate conferred in the PAHO initiative for disease elimination: policy for an Integrated Sustainable Approach to Communicable Diseases in the Americas (Resolution CD57/7, approved by the Directing Council of PAHO in 2019) and in line with the roadmap for neglected tropical diseases 2021-2030 (published by the World Health Organization in 2020)—has supported endemic countries, with which it has developed joint initiatives in favor of strengthening surveillance and control actions, with the goal of reducing severe forms of the disease, through access to early diagnosis, adequate treatment of cases and reduction of contact between people and vectors. The organization of services, the strengthening of knowledge and the technical capacity of professionals in diagnosis and treatment, as well as the strengthening of entomological capacities and the surveillance system to provide updated information, are measures that have been implemented and promoted in the Americas. This report presents the epidemiological situation of leishmaniasis in the Region, through a detailed analysis of the data corresponding to 2019, reported to the Regional Information System of Leishmaniasis in the Americas (SisLeish), as well as infographics of the endemic countries.en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.relation.ispartofseriesLeishmaniases Report;9
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectLeishmaniasisen_US
dc.subjectLeishmaniasis, Visceralen_US
dc.subjectLeishmaniasis, Mucocutaneousen_US
dc.subjectCommunicable Diseasesen_US
dc.subjectZoonosesen_US
dc.subjectEpidemiological Monitoringen_US
dc.subjectNeglected Diseasesen_US
dc.subjectSurveillanceen_US
dc.subjectAmericasen_US
dc.titleLeishmaniases. Epidemiological Report of the Americas, December 2020en_US
dc.typeNewslettersen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/53089en_US
paho.relation.languageVersion10665.2/53091
paho.contributor.departmentCommunicable Diseases and Environmental Determinants of Health (CDE)en_US
paho.iswhotranslationNoen_US
dc.relation.ispartofjournalEpidemiological Report of the Americas
dc.relation.ispartofjournalInforme Epidemiológico das Américas
dc.relation.ispartofjournalInforme Epidemiológico de las Américas


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO